Search Results 81-90 of 11492 for MOTS-c Analogue
... analogues treatment and the study drug as follows ... Hb < 9 g/dL; INR ≥ 1.3; Serum creatinine >2.0 ... C antibody test (anti-HCV); History of, or current ...
Known history of hepatitis B (with positive testing for either hepatitis B surface antigen \[HBsAg\] or hepatitis B core Ab), hepatitis C (HCV) infection ...
Active hepatitis B or C infection based on screening blood testing;; Significant cardiovascular disease, including uncontrolled angina, arrhythmia, recent ...
Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Suarez MD, Misra PP, Soto C, Low PA. Alpha-Synuclein ...
The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...
Del-Carpio Munoz F, Mulpuru S, Luethe E, Carpenter C, Cagin C, Liu K, Chen J, Cha YM, Friedman P, Liu X. Impact of left bundle branch area pacing as the ...
If clinically indicated, IT Ara-C may be given and leukapheresis collection started any time following IT Ara-C. Leukapheresis collection may be started ...
2024 Jan-Feb; 37 (1):95-103 Epub 2023 Dec 20. View PubMed; Zironda A, Zhang C, Day C, McWilliams RR, Starlinger P, Warner SG, Smoot RL, Cleary SP, Kendrick ML ...
Medical record documentation of recurrent Clostridioides difficile infection (rCDI) per the trial definition that includes ≥ 1 recurrence after a primary C.
Molecular Therapy. 2020; doi:10.1016/j.ymthe.2020.12.033. Sakemura R, Cox MJ, Hansen MJ, Hefazi M, Manriquez Roman C ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.